SINGAPORE- Media OutReach- December 20, 2018 - MIMS, a leading multichannel provider of druginformation, medical communications and technology solutions in Asia Pacific,is pleased to announce that it celebratedthree wins at the Media Publishers Association Awards in Singapore on 8^thNovember 2018.

Gracingthe awards night were (from left) MPF Business Director for Singapore JosephineCheong, Peggy Tio (3^rd from left), MIMS CMO Sherlynn Tan, MIMS Doctor Regional Managing EditorElvira Manzano, and MPF Vice President for Hong Kong Karen Lo.

OverallMIMS celebrated three wins. MIMS Doctorcelebrated two wins -- gold and bronze, respectively for the Front Cover of theYear (Trade), for its July 2018 and February 2018 issues. MIMS Doctor designer Peggy Tio clinched the "Designer of the Year"award.

Theawards ceremony was attended by over 35 publishing companies and 180 industrystakeholders.  A panel of six judgeshand-picked the winners. Now on its 12^th year, MPAS Awardsrecognizes local publications and individuals for their remarkable contributionin pushing for relevant content, interesting campaigns and embracing innovation in themedia industry.

"Thishas been a unique opportunity for MIMS, particularly for MIMS Doctor, to punch above its weight and lock our position as oneof the most trusted sources of healthcare information in Asia," said MIMS CEOYasunobu Sakai.  "We are thankful for theawards and we draw strength from the recognition as we continuously reinventourselves and work towards an engaging, cohesive, and progressive community ofdoctors, patients, and healthcare partners."

About MIMS Group

Established in 1963, MIMSis a multichannel provider of drug information, medical education and digitalsolutions connecting healthcare communities. Our work empowers healthcarecommunities to improve patient outcomes by facilitating knowledge exchange andbetter decision-making. Today, MIMS is present in 13 countries (includingTaiwan) across Asia Pacific region with approximately two million healthcareprofessional subscribers to its drug & resource portal, digital and printpublications.